Catalysts for Janssen Therapeutics
248 tracked
Feb 8, 2023
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Feb 8, 2023
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Oct 20, 2022
approval
TOPAMAX (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Oct 20, 2022
approval
TOPAMAX SPRINKLE (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Mar 1, 2022
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Jan 13, 2022
approval
TOPAMAX (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Jan 13, 2022
approval
TOPAMAX SPRINKLE (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Jan 3, 2022
approval
SPRAVATO (ESKETAMINE HYDROCHLORIDE) — FDA approval
Janssen Therapeutics
→
Dec 20, 2021
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Aug 23, 2021
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Jun 30, 2021
approval
TOPAMAX (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Jun 30, 2021
approval
TOPAMAX SPRINKLE (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Jun 25, 2021
approval
CONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
Janssen Therapeutics
→
Jan 28, 2021
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Nov 17, 2020
approval
HALDOL (HALOPERIDOL DECANOATE) — FDA approval
Janssen Therapeutics
→
Nov 17, 2020
approval
HALDOL (HALOPERIDOL DECANOATE) — FDA approval
Janssen Therapeutics
→
Jul 31, 2020
approval
SPRAVATO (ESKETAMINE HYDROCHLORIDE) — FDA approval
Janssen Therapeutics
→
Jun 8, 2020
approval
TOPAMAX (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Jun 8, 2020
approval
TOPAMAX SPRINKLE (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Mar 10, 2020
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Feb 11, 2020
approval
SPRAVATO (ESKETAMINE HYDROCHLORIDE) — FDA approval
Janssen Therapeutics
→
Nov 15, 2019
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Oct 11, 2019
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Aug 23, 2019
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Jun 25, 2019
approval
SPRAVATO (ESKETAMINE HYDROCHLORIDE) — FDA approval
Janssen Therapeutics
→
May 9, 2019
approval
SPRAVATO (ESKETAMINE HYDROCHLORIDE) — FDA approval
Janssen Therapeutics
→
May 2, 2019
approval
TOPAMAX (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
May 2, 2019
approval
TOPAMAX SPRINKLE (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Mar 8, 2019
approval
HALDOL (HALOPERIDOL DECANOATE) — FDA approval
Janssen Therapeutics
→
Mar 5, 2019
approval
SPRAVATO (ESKETAMINE HYDROCHLORIDE) — FDA approval
Janssen Therapeutics
→